CareSaver Network Hopes to Change Coronavirus Outcomes with Pinnacle BioLabs

Testing and early detection is the clinical mission.  The Pinnacle BioLabs COVID-19 Novel Coronavirus Dual IgG/IgM Rapid Test is empowering physicians by providing a 15 minute assay utilizing one drop of whole blood. 

CareSaver Network is proud to offer its customers special access to Pinnacle BioLabs COVID-19 test kits as part of its on-site COVID-19 Testing-Training-Tracking program offered in conjunction with HCIactive

Every Second Counts

Covid-19 is a silent infection in some, and life-threatening to others.  The Pinnacle BioLabs COVID-19 novel Coronavirus Dual IgG/IgM Rapid test detects antibodies in symptomatic and asymptomatic patients, to begin the quarantine process and stops the further spread of the virus.

Early Detection

As with any disease state, early detection is key.  ~99% PPV (“True Positives”) is helpful now – to detect active infections, and later – to detect those with COVID-19 antibodies.  Patient history and symptoms play a critical role in point of care testing, and should always be performed under the guidance of a physician.

Test Anywhere, Anytime

With just 10 µL of blood from a finger stick, the Pinnacle BioLabs COVID-19 novel Coronavirus Dual IgG/IgM Rapid test is mobile, and can be deployed in nursing homes, drive-up testing facilities, ER rooms, or anywhere else it is needed.  In addition to the 5 mL buffer solution, smaller 1 mL bottles are available.